FDA approves first nasal spray flu vaccine for use at home
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year. Health experts say the convenience of the spray — FluMist — could lead to increased flu vaccination rates.
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
FDA Approves 1st Treatment for Niemann-Pick Disease, Type C
FDA, Vanda
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
The producer of Darwin’s Natural Pet Products has refused to recall certain raw cat and dog foods despite the fact that the ...
Drugmaker Cephalon had the FDA's approval to market these drugs, old under brand names like Actiq, as a sweetened lozenge on ...
Consumers should be aware that some chocolate labeled as "dairy-free" actually contains milk, the U.S. Food and Drug ...
“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...
The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...
In its effort to play catch up after thousands of factory inspections were delayed during the coronavirus pandemic, the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback